Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Selected Immunological Mediators and Cervical Microbial Signatures in Women with Chlamydia trachomatis Infection.

Filardo S, Di Pietro M, Tranquilli G, Latino MA, Recine N, Porpora MG, Sessa R.

mSystems. 2019 Jun 4;4(4). pii: e00094-19. doi: 10.1128/mSystems.00094-19.

2.

Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective.

Di Pietro M, Filardo S, Romano S, Sessa R.

Microorganisms. 2019 May 16;7(5). pii: E140. doi: 10.3390/microorganisms7050140. Review.

3.

Growth kinetics of Chlamydia trachomatis in primary human Sertoli cells.

Filardo S, Skilton RJ, O'Neill CE, Di Pietro M, Sessa R, Clarke IN.

Sci Rep. 2019 Apr 10;9(1):5847. doi: 10.1038/s41598-019-42396-3.

4.

Biofilm in Genital Ecosystem: A Potential Risk Factor for Chlamydia trachomatis Infection.

Filardo S, Di Pietro M, Tranquilli G, Sessa R.

Can J Infect Dis Med Microbiol. 2019 Jan 22;2019:1672109. doi: 10.1155/2019/1672109. eCollection 2019.

5.

HPV/Chlamydia trachomatis co-infection: metagenomic analysis of cervical microbiota in asymptomatic women.

Di Pietro M, Filardo S, Porpora MG, Recine N, Latino MA, Sessa R.

New Microbiol. 2018 Jan;41(1):34-41. Epub 2018 Jan 9.

6.

Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.

Di Pietro M, Filardo S, Falasca F, Turriziani O, Sessa R.

Int J Mol Sci. 2017 Nov 18;18(11). pii: E2459. doi: 10.3390/ijms18112459. Review.

7.

Diversity of Cervical Microbiota in Asymptomatic Chlamydia trachomatis Genital Infection: A Pilot Study.

Filardo S, Di Pietro M, Porpora MG, Recine N, Farcomeni A, Latino MA, Sessa R.

Front Cell Infect Microbiol. 2017 Jul 14;7:321. doi: 10.3389/fcimb.2017.00321. eCollection 2017.

8.

Lactobacilli-lactoferrin interplay in Chlamydia trachomatis infection.

Sessa R, Di Pietro M, Filardo S, Bressan A, Mastromarino P, Biasucci AV, Rosa L, Cutone A, Berlutti F, Paesano R, Valenti P.

Pathog Dis. 2017 Jul 31;75(5). doi: 10.1093/femspd/ftx054.

PMID:
28505248
9.

Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation.

Sessa R, Di Pietro M, Filardo S, Bressan A, Rosa L, Cutone A, Frioni A, Berlutti F, Paesano R, Valenti P.

Biochem Cell Biol. 2017 Feb;95(1):34-40. doi: 10.1139/bcb-2016-0049. Epub 2016 Oct 21.

PMID:
28094551
10.

Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients.

Sessa R, Di Pietro M, Filardo S, Bressan A, Mazzuti L, Serafino S, Fantauzzi A, Turriziani O.

New Microbiol. 2017 Jan;40(1):33-37. Epub 2016 Nov 7.

11.

Chlamydia pneumoniae Clinical Isolate from Gingival Crevicular Fluid: A Potential Atherogenic Strain.

Filardo S, Di Pietro M, Schiavoni G, Minniti G, Ortolani E, Romano S, Sessa R.

Front Cell Infect Microbiol. 2015 Nov 25;5:86. doi: 10.3389/fcimb.2015.00086. eCollection 2015.

12.

Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis.

Filardo S, Di Pietro M, Farcomeni A, Schiavoni G, Sessa R.

Mediators Inflamm. 2015;2015:378658. doi: 10.1155/2015/378658. Epub 2015 Aug 9. Review.

13.

Effects of Mentha suaveolens essential oil on Chlamydia trachomatis.

Sessa R, Di Pietro M, De Santis F, Filardo S, Ragno R, Angiolella L.

Biomed Res Int. 2015;2015:508071. doi: 10.1155/2015/508071. Epub 2015 Jan 22.

14.

Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategies.

Di Pietro M, Filardo S, De Santis F, Mastromarino P, Sessa R.

Int J Mol Sci. 2014 Dec 30;16(1):724-35. doi: 10.3390/ijms16010724. Review.

15.

Infectious burden and atherosclerosis: A clinical issue.

Sessa R, Pietro MD, Filardo S, Turriziani O.

World J Clin Cases. 2014 Jul 16;2(7):240-9. doi: 10.12998/wjcc.v2.i7.240. Review.

16.

Effects of vaginal lactobacilli in Chlamydia trachomatis infection.

Mastromarino P, Di Pietro M, Schiavoni G, Nardis C, Gentile M, Sessa R.

Int J Med Microbiol. 2014 Jul;304(5-6):654-61. doi: 10.1016/j.ijmm.2014.04.006. Epub 2014 Apr 28.

PMID:
24875405
17.

Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress.

Guarino MP, Sessa R, Altomare A, Cocca S, Di Pietro M, Carotti S, Schiavoni G, Alloni R, Emerenziani S, Morini S, Severi C, Cicala M.

Dig Liver Dis. 2013 Dec;45(12):1011-6. doi: 10.1016/j.dld.2013.06.001. Epub 2013 Jul 26.

PMID:
23891549
18.

Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.

Di Pietro M, Filardo S, De Santis F, Sessa R.

Int J Mol Sci. 2013 Jul 19;14(7):15105-20. doi: 10.3390/ijms140715105. Review.

19.

Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease.

Sessa R, Di Pietro M, Schiavoni G, Petrucca A, Cipriani P, Zagaglia C, Nicoletti M, Santino I, del Piano M.

Atherosclerosis. 2007 Nov;195(1):e224-30. Epub 2007 Jun 18.

PMID:
17575984
20.

Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability.

Romano S, Penco M, Fratini S, Di Pietro M, Sessa R, Del Piano M, Fedele F, Dagianti A.

Int J Cardiol. 2004 May;95(1):95-9.

PMID:
15159045

Supplemental Content

Loading ...
Support Center